Stock

ALNY US

ALNYLAM PHARMACEUTICALS INC · NASDAQ · USD · Healthcare

Insiders net selling (90d) — usually routine

$255.96

+6.37 (+2.55%)

Price session: 2026-09-25 · Observed: 25 Sept 2026, 23:00 KSA · Source: delayed quote

Easy Score

Weak

Value

Momentum

Trend

Three engines, 0–100 each. Analysis, not financial advice.

Why is it moving?auto-generated

ALNY +2.55% today · volume in line with average · 1 recent headline — latest not assessed: “Alnylam Needs Stronger Amvuttra Execution To Justify More Upside”.

Latest headlines

• Alnylam Needs Stronger Amvuttra Execution To Justify More Upside

Priceinteractive — your checked tools draw on it

Daily is the finest granularity · last ~6 months

RSI (14)

Patterns detected:

CloseMA 50MA 200check tools below to add them to the chart

Key technicals & risksame engine as the score

RSI (14)

55.9

MACD hist.

+0.62

50-day MA

$244.29

200-day MA

$306.95

ATR (14)

$10.03

Avg volume (20d)

1.6M

Volatility

47%

Max drawdown

-58%

Beta vs S&P

0.42

Daily plain-language briefs are a Pro feature.

Signal mix18

bullish

neutral

bearish

Every tool the engine can compute from stored bars. Check tools on the chart to see each one.

Street consensus38 analysts

Buy29

Hold9

Sell0

Forecast two independent reads

System

USD 247.63USD 266.08

Yours · 2 tools

USD 247.63USD 266.08

Model anchor (last stored close)

USD 255.96

USD 246.52USD 267.19

Computed from: USD 255.96 · session 2026-09-25 · 2509 historical windows

Lean score +0.00 — 0 bullish / 0 bearish / 2 neutral among your checked tools, weighted for this horizon. Your overlay is an exploratory scenario, not a calibrated prediction. The historical baseline stays unchanged. The system band is the 25th–75th percentile of this stock’s own historical moves for the horizon.